• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

AMO, B&L enter into phaco patent agreement

Article

Advanced Medical Optics and Bausch & Lomb have entered into an agreement regarding AMO's patent entitled "Fluid Management Systems with Vertex Chamber" (No. 6,059,765) and its foreign counterparts, all of which relate to peristaltic pump fluidics used in phacoemulsification systems.

Santa Ana, CA, and Rochester, NY-Advanced Medical Optics (AMO) and Bausch & Lomb (B&L) have entered into an agreement regarding AMO's patent entitled "Fluid Management Systems with Vertex Chamber" (No. 6,059,765) and its foreign counterparts, all of which relate to peristaltic pump fluidics used in phacoemulsification systems.

Under the terms of the agreement, B&L will pay AMO a royalty. Other terms were not disclosed.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.